Jordan Translational Medicine Lecture
The Jordan Translational Medicine Lecture was established following a donation by Professor Craig Jordan (University of Texas MD Anderson Cancer Center) to support an annual lecture in the area of translational research.
|2022||Dr Vishva Dixit,
Vice-President, Early Discovery Research, Genentech Inc.
|Why so many ways to die?|
|2019||Prof Fiona Watt
Director, King’s Centre for Stem Cells & Regenerative Medicine, Executive Chair of the MRC
|Mechanisms controlling homeostasis in mammalian epidermis|
|2018||Prof Patrick Cramer
Director, Max Plank Institute of Biophysical Chemistry
|How to switch on human genes|
Kyoto University, Japan
|Cancer immunotherapy by blockade of the lymphocyte surface receptor PD-1|
Wellcome Centre for Cell Biology, UK
|Genetic and epigenetic roots of an autism spectrum disorder|
iPS technology, gene editing and disease research
Georgetown University, USA
|Evolution of Endocrine therapy for Breast cancer - the Paradox of Estrogen Induced Apoptosis|
About Professor Jordan
Professor Jordan discovered the biology of a group of medicines now called Selective Estrogen Receptor Modulators (SERMs). These medicines prevent osteoporosis, decrease coronary heart disease and treat and prevent breast cancer. Tamoxifen is the first SERM that has been used as a long-term adjuvant therapy, significantly increasing survival rates for breast cancer patients. The FDA in the United States has approved five SERMs, all of which are connected to Prof Jordan's research. Prof Jordan is a member of the National Academy of Sciences and the National Academy of Medicine, and a Fellow of the Academy of Medical Science. In 2016, he was named one of four individuals who have changed women’s healthcare in the 21st Century and the American Society for Clinical Oncology recognized the impact of his translational research to medical practice. The Jordan Translational Medical Lecture focuses on encouraging further success in translational research.